China's Tasly Pharma said to mull listing biotech unit in $1b Hong Kong IPO

China's Tasly Pharma said to mull listing biotech unit in $1b Hong Kong IPO

Photo: Tasly website

Julie Zhu, Fiona Lau

05 March, 2018

Hong Kong Exchanges & Clearing (HKEX)Tasly Pharmaceutical

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.